Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) FCF Margin (2016 - 2026)

Ekso Bionics Holdings has reported FCF Margin over the past 13 years, most recently at 141.94% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 11338.0% to 141.94% in Q4 2025 year-over-year; TTM through Dec 2025 was 93.67%, a 3854.0% decrease, with the full-year FY2025 number at 93.67%, down 3854.0% from a year prior.
  • FCF Margin reached 141.94% in Q4 2025 per EKSO's latest filing, down from 49.04% in the prior quarter.
  • The five-year high for FCF Margin was 28.57% in Q4 2024, with the low at 169.37% in Q2 2025.
  • The 5-year median for FCF Margin is 81.61% (2022), against an average of 91.2%.
  • Peak YoY movement for FCF Margin: soared 7054bps in 2023, then tumbled -11543bps in 2025.
  • Tracing EKSO's FCF Margin over 5 years: stood at 75.42% in 2021, then crashed by -38bps to 104.11% in 2022, then soared by 68bps to 33.57% in 2023, then increased by 15bps to 28.57% in 2024, then tumbled by -397bps to 141.94% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 141.94%, 49.04%, and 169.37% for Q4 2025, Q3 2025, and Q2 2025 respectively.